MSMB
Beta-microseminoprotein
Also known as: IGBF, MSMB_HUMAN, MSP, MSPB, PN44, PRPS, PSP, PSP-94, PSP57, PSP94
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P08118
- Gene
- MSMB
- Ensembl
- ENSG00000263639
- Chromosome
- 10
- Canonical length
- 114 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins
- Secretome location
- Secreted in male reproductive system
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a member of the immunoglobulin binding factor family. It is synthesized by the epithelial cells of the prostate gland and secreted into the seminal plasma. This protein has inhibin-like activity. It may have a role as an autocrine paracrine factor in uterine, breast and other female reproductive tissues. The expression of the encoded protein is found to be decreased in prostate cancer. Two alternatively spliced transcript variants encoding different isoforms are described for this gene. The use of alternate polyadenylation sites has been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
114 residues, UniProt reviewed canonical sequence.
>P08118|MSMB
1 MNVLLGSVVI FATFVTLCNA SCYFIPNEGV PGDSTRKCMD LKGNKHPINS EWQTDNCETC
61 TCYETEISCC TLVSTPVGYD KDNCQRIFKK EDCKYIVVEK KDPKKTCSVS EWIILocalizationUniProt · AlphaFold · HPA
Whether an antibody against MSMB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 8,772 nTPM
Expression across tissuesHPA
Tissue
- prostate: 8,772 nTPM
- stomach: 521 nTPM
- epididymis: 43 nTPM
- skin: 39 nTPM
- salivary gland: 32 nTPM
- lung: 31 nTPM
Single-cell type
- prostatic glandular cells: 24,516 nCPM
- conjunctival goblet cells: 5,014 nCPM
- respiratory secretory cells: 3,957 nCPM
- respiratory deuterosomal cells: 2,429 nCPM
- submucosal glandular cells: 864 nCPM
- foveolar cells: 359 nCPM
Immune cell
- eosinophil: 0.2 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 0.1 nTPM
- medulla oblongata: 0.1 nTPM
- pons: 0.1 nTPM
- white matter: 0.1 nTPM
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MSMB.
Disease | AllUniProt
Conditions MSMB is implicated in, by any mechanism.
- Prostate cancer, hereditary, 13 (HPC13) MIM:611928
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.58
- gnomAD pLI
- 0.02
- gnomAD missense Z
- 0.79
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MSMB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MSMB as an antibody target. Whether an autoantibody or antibody against MSMB could matter depends on whether native MSMB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MSMB is annotated as secreted, so native MSMB circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label MSMB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...